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Living with chronic kidney disease (CKD) is associated with hardships for patients and their care partners. Empowering
patients and their care partners, including family members or friends involved in their care, may help minimize the burden
and consequences of CKD-related symptoms to enable life participation. There is a need to broaden the focus on living well
with kidney disease and re-engagement in life, including an emphasis on patients being in control. The World Kidney Day
(WKD) Joint Steering Committee has declared 2021 the year of ‘Living Well with Kidney Disease’ in an effort to increase
education and awareness on the important goal of patient empowerment and life participation. This calls for the
development and implementation of validated patient-reported outcome measures to assess and address areas of life
participation in routine care. It could be supported by regulatory agencies as a metric for quality care or to support labeling
claims for medicines and devices. Funding agencies could establish targeted calls for research that address the priorities of
patients. Patients with kidney disease and their care partners should feel supported to live well through concerted efforts
by kidney care communities including during pandemics. In the overall wellness program for kidney disease patients, the
need for prevention should be reiterated. Early detection with a prolonged course of wellness despite kidney disease, after
effective secondary and tertiary prevention programs, should be promoted. WKD 2021 continues to call for increased
awareness of the importance of preventive measures throughout populations, professionals and policymakers, applicable
to both developed and developing countries.
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PATIENT PRIORITIES FOR LIVING WELL: A
FOCUS ON LIFE PARTICIPATION
Chronic kidney disease (CKD), its associated symptoms and
its treatment, including medications, dietary and fluid restric-
tions, and kidney replacement therapy, can disrupt and con-
strain daily living and impair the overall quality of life of
patients and their family members. Consequently, this can
also impact treatment satisfaction and clinical outcomes [1].
Despite this, the past several decades have seen limited im-
provement in the quality of life of people with CKD [1]. To
advance research, practice and policy, there is increasing rec-
ognition of the need to identify and address patient priorities,
values and goals [1].
Several regional and global kidney health projects have
addressed these important questions including the
Standardized Outcomes in Nephrology (SONG) with more
than 9000 patients, family members and health professionals
from over 70 countries [2, 3]. Across all treatment stages, in-
cluding CKD, dialysis and transplantation, SONG participating
children and adults with CKD consistently gave higher prior-
ity to symptoms and life impacts than health professionals
[2, 3]. In comparison, health professionals gave higher priority
to mortality and hospitalization than patients and family
members. The patient-prioritized outcomes are shown in
Figure 1. Irrespective of the type of kidney disease or treat-
ment stage, patients wanted to be able to live well, maintain
their role and social functioning, protect some semblance of
normality, and have a sense of control over their health and
wellbeing.
Life participation, defined as the ability to do meaningful
activities of life including, but not limited to, work, study,
family responsibilities, travel, sport, social and recreational
activities, was established a critically important outcome
across all treatment stages of CKD [1, 2]. The quotations from
patients with kidney disease provided in Box 1 demonstrate
how life participation reflects the ability to live well with
CKD [4]. According to the World Health Organization (WHO),
participation refers to ‘involvement in a life situation’ [5].
This concept is more specific than the broader construct of
quality of life. Life participation places the life priorities and
values of those affected by CKD and their family at the cen-
ter of decision-making. The World Kidney Day (WKD)
Steering Committee calls for the inclusion of life participa-
tion, a key focus in the care of patients with CKD, to achieve
the ultimate goal of living well with kidney disease. This calls
for the development and implementation of validated
patient-reported outcome measures, which could be used to
assess and address areas of life participation in routine care.
Monitoring of life participation could be supported by regula-
tory agencies as a metric for quality care or to support label-
ing claims for medicines and devices. Funding agencies could
establish targeted calls for research that address the priorities
of patients, including life participation.
PATIENT EMPOWERMENT, PARTNERSHIP AND
A PARADIGM SHIFT TOWARD A STRENGTHS-
BASED APPROACH TO CARE
Patients with CKD and their family members including care
partners should be empowered to achieve the health outcomes
and life goals that are meaningful and important to them. The
WHO defines patient empowerment as ‘a process through
which people gain greater control over decisions or actions af-
fecting their health’, [6] which requires patients to understand
their role, to have knowledge to be able to engage with clini-
cians in shared decision-making, skills and support for self-
management. For patients receiving dialysis, understanding the
rationale for a lifestyle change, having access to practical assis-
tance and family support promoted patient empowerment,
while feeling limited in life participation undermined their
sense of empowerment [7].
The WKD Steering Committee advocates for strengthened
partnership with patients in the development, implementation
and evaluation of interventions for practice and policy settings
that enable patients to live well with kidney diseases. This
needs to be supported by consistent, accessible and meaningful
communication. Meaningful involvement of patients and fam-
ily members across the entire research process, from priority
setting and planning the study through to dissemination and
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implementation, is now widely advocated [8]. There have also
been efforts, such as the Kidney Health Initiative, to involve
patients in the development of drugs and devices to foster inno-
vation [9].
We urge for greater emphasis on a strengths-based ap-
proach as outlined in Table 1, which encompasses strategies
to support patient resilience, harness social connections,
build patient awareness and knowledge, facilitate access to
support, and establish confidence and control in self-
management. The strengths-based approach is in contrast to
the medical model where chronic disease is traditionally fo-
cused on pathology, problems and failures [10]. Instead, the
strengths-based approach acknowledges that each individual
has strengths and abilities to overcome the problems and
challenges faced, and requires collaboration and cultivation
of the patient’s hopes, aspirations, interests and values.
Efforts are needed to ensure that structural biases, discrimi-
nation and disparities in the healthcare system also need to
be identified, so all patients are given the opportunity to
have a voice.
FIGURE 1: Conceptual framework of ‘Living Well with Kidney Disease’ based on patient centeredness and empowering patient with focus on effective symptom man-
agement and life participation.
Box 1. Quotations from patients with CKD related to priorities for living well
‘I don’t want to think about dying from my disease. I want to be able to live well with my disease.’—Patient with CKD
‘Life participation is most important because without it, you can’t do anything.’—Child with CKD
‘Maybe it’s as simple as asking patients whether, how well they are able to participate in the life that they want to lead because it’s going
to be different for different people.’—Kidney transplant recipient
‘Everyone has to face death, what I would like to have is a good quality of life rather than to face death.’—Kidney transplant recipient
‘So, it doesn’t actually really matter what the numbers say, and some of my numbers should have suggested that I should be feeling a lot
worse than what I actually was, it’s about how much I feel I can do and participate in my life and feel normal.’—Patient with CKD
‘I’m still living. I get out of bed, and I’m still living and still breathing. As long as I can do that, I’m going to carry on and be positive be-
cause life is short.’—Patient with CKD
‘I put life participation because I know that looking from the outside, I know [his kidney disease] stops [him] from thinking bigger. . .
Although that’s really big, there’s this life that has to happen at the same time.’—Family member
‘Amazed at comments from professional (sic) about travel, free time, etc. they seem to think the mechanics of dialysis far more impor-
tant. Dialysis is a treatment which keeps us alive to live a life, not just to wait for death.’—Patient receiving dialysis
‘I prefer to be above ground, then below ground. So why not enjoy life whilst being above ground.’—Adam Martin*
‘Over the years, I have learned to worry less, control my emotions, and not fear death. I keep my mind active. I follow the advice of the
philosopher-emperor Marcus Aurelius to ‘love the hand that fate (has dealt me) and play it as (my) own’. Living well with CKD means
to live the best life I can in the time I have available. . . Living well with CKD is the same as living well.’—Tess Harris*
‘While CKD brings me some limitations, I can maximize the possibility to live well. I kept working when I was doing hemodialysis. After
transplant, I could live: study, work, travel, marry, have children, and service the community.’—Maggie Ng*
*Personal communication; quotations are identified by name with permission.
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THE ROLE OF CARE PARTNER
A care partner is often an informal caregiver who is also a fam-
ily member of the patient with CKD [11]. They may take on a
wide range of responsibilities including coordinating care (in-
cluding transportation to appointments), administration of
treatment including medications, home dialysis assistance and
supporting dietary management. Caregivers of patients with
CKD have reported depression, fatigue, isolation and also burn-
out. The role of the care partner has increasingly become more
important in CKD care given the heightened complexity in com-
municative and therapeutic options including the expansion of
telemedicine under the coronavirus disease 2019 (COVID-19)
pandemic and given the goal to achieve higher life expectancy
with CKD [12]. The experience of caring for a partially incapaci-
tated family member with progressive CKD can represent a sub-
stantial burden on the care partner and may impact family
dynamics. Not infrequently, the career goals and other occupa-
tional and leisure aspects of the life of the care partner are af-
fected because of CKD care partnership, leading to care partner
overload and burnout. Hence, the abovementioned principles of
life participation need to equally apply to care partners as well
as all family members and friends involved in CKD care.
LIVING WITH KIDNEY DISEASE IN
LOW-INCOME REGIONS
In low- and lower-middle-income countries (LICs and LMICs) in-
cluding in sub-Saharan Africa, South East Asia and Latin
America, patients’ ability to self-manage or cope with the
chronic disease vary but may often be influenced by internal
factors including spirituality, belief system and religiosity, and
external factors including appropriate knowledge of the disease,
poverty, family support system and one’s grit and social rela-
tions network. The support system comprising healthcare
providers and caregivers plays a crucial role as most patients
rely on them in making decisions, and for the necessary adjust-
ments in their health behavior [13]. In LIC regions, where there
are often a relatively low number of physicians and even lower
number of kidney care providers per population especially in ru-
ral areas, a stepwise approach can involve local and national
stakeholders including both nongovernmental organizations
and government agencies by (i) extending kidney patient educa-
tion in rural areas, (ii) adapting telehealth technologies if feasi-
ble to educate patients and train local community kidney care
providers and (iii) implementing effective retention strategies
for rural kidney health providers including adapting career
plans and competitive incentives.
Many patients in low-resource settings present in very late
stage, needing to commence emergency dialysis [14]. The very
few fortunate ones to receive kidney transplantation may ac-
quire an indescribable chance at normal life again, notwith-
standing the high costs of immunosuppressive medications in
some countries. For some patients and care partners in low-
income regions, spirituality and religiosity may engender hope:
when ill they are energized by the anticipation of restored
health and spiritual well-being. For many patients, informing
them of a diagnosis of kidney disease is a harrowing experience
both for the patient (and caregivers) and the healthcare profes-
sional. Most patients present to kidney physicians (usually
known as ‘renal physicians’ in many of these countries) with
trepidation and apprehension. It is rewarding therefore to see
the patient’s anxiety dissipate after reassuring him or her of a
diagnosis of simple kidney cysts, urinary tract infection, simple
kidney stones, solitary kidneys, etc., that would not require ex-
treme measures like kidney replacement therapy. Patients diag-
nosed with glomerulonephritis who have an appropriate
characterization of their disease from kidney biopsies and his-
tology, who receive appropriate therapies and achieve remis-
sion, are relieved and are very grateful. Patients are glad to
Table 1. Suggested strategies for living well with CKD using a strengths-based approach
Strengths-based approach Suggested strategies
Build resilience • Identify or provide strategies and resources to manage stress and functioning when en-
countering challenges, adversity and trauma (e.g. commencement of dialysis)
Harness social connections • Facilitate connections with other patients to learn coping strategies and for support
• Support family members/caregivers
Build awareness and knowledge • Provide education (including practical advice) on diet and lifestyle modifications
• Understand, identify and address the potential impacts of CKD (e.g. cognitive function)
• Encourage patients to ask questions
• Encourage the use of knowledge to empower and prepare for the future
Facilitate access to support • Refer to allied healthcare professionals (e.g. dietitian, social worker, mental health pro-
fessionals, occupation therapists)
• Provide support that enables the patient to participate in important life activities, e.g.
work
Establish confidence and control in
self-management
• Support informed and shared decision-making (including dialysis, kidney transplanta-
tion, conservative or nondialytic care)
• Encourage patients to learn to ‘get in tune’ with what works well for them and to voice
any concerns, and work together to develop better management strategies to enable
patients to feel better
• Provide strategies to prevent or manage complications (e.g. infection)
• Support open communication regarding goals, concerns and priorities
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discontinue dialysis following resolution of acute kidney injury
or acute on CKD.
Many CKD patients who have residual kidney function ap-
preciate being maintained in a relatively healthy state with con-
servative measures, without dialysis. They experience renewed
energy when their anemia is promptly corrected using
erythropoiesis-stimulating agents. They are happy when their
peripheral edema resolves with treatment. For those on mainte-
nance hemodialysis who had woeful stories from emergency
femoral cannulations, they appreciate the construction of good
temporary or permanent vascular accesses. Many patients in
low-resource settings present in very late stage needing to com-
mence emergency dialysis. Patients remain grateful for waking
from a uremic coma or recovering from recurrent seizures when
they commence dialysis.
WORLD KIDNEY DAY 2021 ADVOCACY
WKD 2021 theme of ‘Living Well with Kidney Disease’ is deliber-
ately chosen to have the goals to redirect more focus on plans
and actions toward achieving patient-centered wellness.
‘Kidney Health for Everyone, Everywhere’ with emphasis on
patient-centered wellness should be a policy imperative that
can be successfully achieved if policymakers, nephrologists,
healthcare professionals, patients and care partners place this
within the context of comprehensive care. The requirement of
patient engagement is needed. In 2016 the WHO put out an im-
portant document on patient empowerment (WHO 2016):
‘Patient engagement is increasingly recognized as an integral
part of health care and a critical component of safe people-
centred services. Engaged patients are better able to make in-
formed decisions about their care options. In addition, resour-
ces may be better used if they are aligned with patients’
priorities and this is critical for the sustainability of health sys-
tems worldwide. Patient engagement may also promote mutual
accountability and understanding between patients and health
care providers. Informed patients are more likely to feel confi-
dent to report both positive and negative experiences and have
increased concordance with mutually agreed care management
plans. This not only improves health outcomes but also advan-
ces learning and improvement while reducing adverse events.’
In the International Society of Nephrology (ISN) Community
Film Event at World Congress of Nephrology 20 (ISN
Community Film Event 2020), it is good to see a quote in the
film from patients: ‘Tell me. I will forget; Show me. I will re-
member; Involve me. I will understand.’ ISN Global Kidney
Policy Forum 2019 included a patient speaker Nicki Scholes-
Robertson from New Zealand: ‘Culturally appropriate and sensi-
tive patient information and care are being undertaken in New
Zealand to fight inequities in kidney health, especially in Maori
and other disadvantaged communities.’
WKD 2021 would like to promote to the policymakers in-
creasing focus and resources on both drug and nondrug pro-
grams in improving patient wellness. Examples include funding
for erythropoiesis-stimulating agents and anti-pruritic agents
for managing anemia and itchiness, respectively, to name but a
few [15, 16]. Home dialysis therapies have been consistently
found to improve patient autonomy and flexibility, and quality
of life in a cost-effective manner, enhancing life participation.
Promoting home dialysis therapies should tie in with appropri-
ate ‘assisted dialysis’ programs to reduce patient and care part-
ner fatigue and burnout. Also, examples like self-management
programs, cognitive behavioral therapy and group therapies for
managing depression, anxiety and insomnia should be
promoted before resorting to medications [17]. The principle of
equity recognizes that different people with different levels of
disadvantage require different approaches and resources to
achieve equitable health outcomes. The kidney community
should push for adapted care guidelines for vulnerable and dis-
advantaged populations. The involvement of primary care and
general physicians, especially in LICs and LMICs, would be use-
ful in improving the affordability and access to services through
the public sector in helping the symptom management of CKD
patients and improving their wellness. In the overall wellness
program for kidney disease patients, the need for prevention
should be reiterated. Early detection with a prolonged course of
wellness despite kidney disease, after an effective secondary
prevention program, should be promoted [18]. Prevention of
CKD progression can be attempted by lifestyle and diet modifi-
cations such as a plant-dominant low-protein diet and by
means of effective pharmacotherapy including administration
of sodium–glucose co-transporter 2 inhibitors [19]. WKD 2021
continues to call for increased awareness of the importance of
preventive measures throughout populations, professionals
and policymakers, applicable to both developed and developing
countries [18].
CONCLUSIONS
Effective strategies to empower patients and their care partners
strive to pursue the overarching goal of minimizing the burden
of CKD-related symptoms in order to enhance patient satisfac-
tion, health-related quality of life and life participation. The
WKD 2021 theme of ‘Living Well with Kidney Disease’ is deliber-
ately chosen to have the goals to redirect more focus on plans
and actions toward achieving patient-centered wellness.
Notwithstanding the COVID-19 pandemic that has overshad-
owed many activities in 2020 and beyond, the WKD Steering
Committee has declared 2021 the year of ‘Living Well with
Kidney Disease’ in an effort to increase education and aware-
ness on the important goal of effective symptom management
and patient empowerment. Whereas the WKD continues to em-
phasize the importance of effective measures to prevent kidney
disease and its progression [18], patients with preexisting kid-
ney disease and their care partners should feel supported to live
well through concerted efforts by kidney care communities and
other stakeholders throughout the world, even during a world-
shattering pandemic such as COVID-19 that may drain many
resources [20]. Living well with kidney disease is an uncompro-
misable goal of all kidney foundations, patient groups and pro-
fessional societies alike, to which the ISN and the International
Federation of Kidney Foundation World Kidney Alliance are
committed at all times.
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